Blood Screening Market Size Share Growth Trends & Industry Report 2030

Blood Screening Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Global Blood Screening Market is segmented&nbsp;By Product Type (Instruments&nbsp; (Outright Purchase, Rental Purchase),&nbsp;Reagents &amp; Kits (NAT Reagents &amp; Kits, ELISA Reagents &amp; Kits, Other Reagents),&nbsp;&nbsp;Software and Services),&nbsp;By&nbsp;Technology (Next-Generation Sequencing, Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay (ELISA, By Platform,&nbsp;ELISA, By Generation,&nbsp;Western Blot Assay,&nbsp;Rapid Tests, others)),&nbsp;By&nbsp;End-Users (Hospitals, Blood Banks, others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

&nbsp;

<h3>Blood Screening Market Overview</h3>

<blockquote>
Global Blood Screening Market reached US$ YY&nbsp;billion in 2022 and is expected to reach US$ YY&nbsp; million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
</blockquote>

Blood screening tests are performed to identify infection signs in order to stop the distribution of contaminated blood and blood components for clinical use. A blood screening test is done to detect potential health disorders or diseases in people who do not have any symptoms of the disease.

Blood screening strategies are designed to assure the safety of blood units, but should not be used for notifying blood donors of reactive test results. Various technologies are used in blood screening tests which include next-generation sequencing, nucleic acid tests, and ELISA.

<h3>Blood Screening Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product Type, Technology, End Users
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report <a href="https://www.datamintelligence.com/download-sample/blood-screening-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Blood Screening Market Dynamics</h3>

Increasing launches of blood screening tests

Blood screening tests are performed on a blood sample to provide valuable information and diagnose specific medical conditions. The increasing number of product launches for blood screening tests acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new blood screening tests and kits.

For instance, in October 2023, Delfi Diagnostics launched a blood-based lung cancer screening test. It aims to provide a more convenient detection method and one that&rsquo;s capable of reaching a greater number of people than the current standard.

Additionally, in August 2023, Quest Diagnostics introduced its AD-Detect test for Alzheimer&rsquo;s disease in the United States by making it the first blood-based biomarker test available for consumers to purchase and assess the potential risks of developing Alzheimer&rsquo;s disease.

Furthermore, the global blood screening market is driven by various factors like rising blood donations, and an increase in the incidence of infectious diseases is expected to drive the market in the forecast period.

The stringent regulatory approvals and high cost of blood screening equipment

Stringent regulatory requirements can slow the approval and adoption of new blood screening technologies or tests. Also, the high cost associated with blood screening equipment can hamper the market growth.&nbsp;

<h3>Blood Screening Market Segment Analysis</h3>

The global blood screening market is segmented based on product type, technology, end users, and region.

Reagents and kits accounted for approximately 48.4% of the market share&nbsp;

The anti-A, anti-B, and anti-A, B reagents are used in the red blood cell determination of the ABO blood group. They are used to determine the absence or presence of erythrocytic antigens A or B on the surface of human red blood cells. Reagents and kits are expected to hold the largest market share over the period forecast owing to the high requirement for reagents, kits, and product launches.&nbsp;

For instance, in June 2023, Sysmex launched an assay kit to identify Amyloid Beta (A&beta;) accumulation in the brain that causes&nbsp; Alzheimer&rsquo;s disease by using a small amount of blood.&nbsp;

Additionally, in July 2021, Ortho Clinical Diagnostics launched its VITROS Immunodiagnostic Products IL-6 Reagent Pack which is the latest addition to Ortho&#39;s VITROS Critical Care blood screening menu.

<h3>Global Blood Screening Market Geographical Analysis</h3>

North America is expected to hold a significant position in the global blood screening market share

The global blood screening market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.&nbsp;

North America has maintained a significant market proportion due to factors such as the rising blood transfusion rates, and product launches, this trend is anticipated to continue throughout the forecast period.

For instance, according to the American Red Cross, in the United States, an estimated 10,000 units of plasma, roughly 7,000 units of platelets, and 36,000 units of red blood cells are needed per day. In the United States, more than 21 million blood components are transfused annually.

Additionally, in September 2023, Oxford BioDynamics, Plc. launched its 94% accurate EpiSwitch prostate screening blood test for men with prostate cancer risk.&nbsp;

<h3>COVID-19 Impact Analysis&nbsp;</h3>

The COVID-19 pandemic has had a significant impact on the global blood screening market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the blood screening market is expected to be moderately affected over the forecast period.

<h3>Competitive Landscape</h3>

The major global players in the market include Bio-Rad Laboratories, Inc., Grifols S.A, Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, Biom&eacute;rieux, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Beckman Coulter (Danaher Corporation). among others.

<h3>Key Developments</h3>

<ul>
	<li>In March 2023, H.U. Group Holdings Inc. introduced the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems. These CLEIA (chemiluminescent enzyme immunoassay) assays allow for the quantitative measurement of Neurofilament light (NfL) in human cerebrospinal fluid (CSF) and plasma.</li>
	<li>In June 2021, Grail launched the Galleri blood screening test which is a multi-cancer screening capable of detecting many cancers.&nbsp;</li>
</ul>

Why Purchase the Report?

<ul>
	<li>To visualize the global blood screening market segmentation based on product type, technology, end users and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of blood screening market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global blood screening market report would provide approximately 61 tables, 58 figures, and 185 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Technology</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing launches of blood screening tests</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>The stringent regulatory approvals and high cost of blood screening equipment</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type&nbsp;</li>
		</ol>
		</li>
		<li>Instruments*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
			<li>Outright Purchase</li>
			<li>Rental Purchase</li>
		</ol>
		</li>
		<li>Reagents &amp; Kits
		<ol>
			<li>NAT Reagents &amp; Kits
			<ol>
				<li>Standards and Controls</li>
				<li>Labeling and Detection Reagents</li>
				<li>Enzymes and Polymerases</li>
				<li>Probes and Primers</li>
				<li>Buffers, Nucleotides, and Solutions</li>
			</ol>
			</li>
			<li>ELISA Reagents &amp; Kits
			<ol>
				<li>conjugates (Antigen Or Antibody-Conjugated Enzyme)</li>
				<li>Immunosorbents</li>
				<li>Controls</li>
				<li>Substrates</li>
				<li>Sample Diluents and Wash Solutions</li>
				<li>Other Reagents&nbsp;</li>
			</ol>
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>Next-Generation Sequencing (NGS) *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Next-Generation Sequencing (NGS)
		<ol>
			<li>Real-Time Polymerase Chain Reaction (PCR)</li>
			<li>Transcription-Mediated Amplification (TMA)</li>
		</ol>
		</li>
		<li>Enzyme-Linked Immunosorbent Assay (ELISA)
		<ol>
			<li>ELISA, By Platform
			<ol>
				<li>Fluorescence Immunoassay (FIA)</li>
				<li>Chemiluminescence Immunoassay (CLIA)</li>
				<li>Colorimetric Immunoassay (CI)</li>
			</ol>
			</li>
			<li>ELISA, By Generation
			<ol>
				<li>First-Generation ELISA</li>
				<li>Second-Generation ELISA</li>
				<li>Third-Generation ELISA</li>
				<li>Fourth-Generation &amp; Above</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Western Blot Assay</li>
		<li>Rapid Tests</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End Users</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Attractiveness Index, By End Users</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Blood Banks</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Bio-Rad Laboratories, Inc.
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Grifols&nbsp;</li>
		<li>Abbott Laboratories&nbsp;</li>
		<li>F. Hoffmann-La Roche&nbsp;</li>
		<li>Siemens Healthineers</li>
		<li>Biom&eacute;rieux&nbsp;</li>
		<li>Thermo Fisher Scientific, Inc.&nbsp;</li>
		<li>Ortho Clinical Diagnostics, Inc.&nbsp;</li>
		<li>Becton, Dickinson, and Company</li>
		<li>Beckman Coulter (Danaher Corporation)&nbsp;(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;

<ul>
</ul>

List of Tables

Table 1 Global Blood Screening Market Value, By Technology, 2021,2026 &amp; 2030 ($ Million)

Table 2 Global Blood Screening Market Value, By Product Type, 2021,2026 &amp; 2030 ($ Million)

Table 3 Global Blood Screening Market Value, By End-User, 2021,2026 &amp; 2030 ($ Million)

Table 4 Global Blood Screening Market Value, By Region, 2021,2026 &amp; 2030 ($ Million)

Table 5 Global Blood Screening Market Value, By Technology, 2021,2026 &amp; 2030 ($ Million)

Table 6 Global Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 7 Global Blood Screening Market Value, By Product Type, 2021,2026 &amp; 2030 ($ Million)

Table 8 Global Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 9 Global Blood Screening Market Value, By End-User, 2021,2026 &amp; 2030 ($ Million)

Table 10 Global Blood Screening Market Value, By End-User, 2021-2030 ($ Million)

Table 11 Global Blood Screening Market Value, By Region, 2021,2026 &amp; 2030 ($ Million)

Table 12 Global Blood Screening Market Value, By Region, 2021-2030 ($ Million)

Table 13 North America Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 14 North America Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 15 North America Blood Screening Market Value, By End-User, 2021-2030 ($ Million)

Table 16 North America Blood Screening Market Value, By Country, 2021-2030 ($ Million)

Table 17 South America Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 18 South America Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 19 South America Blood Screening Market Value, By End-User, 2021-2030 ($ Million)

Table 20 South America Blood Screening Market Value, By Country, 2021-2030 ($ Million)

Table 21 Europe Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 22 Europe Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 23 Europe Blood Screening Market Value, By End-User, 2021-2030 ($ Million)

Table 24 Europe Blood Screening Market Value, By Country, 2021-2030 ($ Million)

Table 25 Asia-Pacific Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 26 Asia-Pacific Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 27 Asia-Pacific Blood Screening Market Value, By End-User, 2021-2030 ($ Million

Table 28 Asia-Pacific Blood Screening Market Value, By Country, 2021-2030 ($ Million)

Table 29 Middle East &amp; Africa Blood Screening Market Value, By Technology, 2021-2030 ($ Million)

Table 30 Middle East &amp; Africa Blood Screening Market Value, By Product Type, 2021-2030 ($ Million)

Table 31 Middle East &amp; Africa Blood Screening Market Value, By End-User, 2021-2030 ($ Million)

Table 32 Bio-Rad Laboratories, Inc.: Overview

Table 33 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 34 Bio-Rad Laboratories, Inc.: Key Developments

Table 35 Grifols: Overview

Table 36 Grifols: Product Portfolio

Table 37 Grifols: Key Developments

Table 38 Abbott Laboratories: Overview

Table 39 Abbott Laboratories: Product Portfolio

Table 40 Abbott Laboratories: Key Developments

Table 41 F. Hoffmann-La Roche: Overview

Table 42 F. Hoffmann-La Roche: Product Portfolio

Table 43 F. Hoffmann-La Roche: Key Developments

Table 44 Siemens Healthineers: Overview

Table 45 Siemens Healthineers: Product Portfolio

Table 46 Siemens Healthineers: Key Developments

Table 47 Biom&eacute;rieux : Overview

Table 48 Biom&eacute;rieux: Product Portfolio

Table 49 Biom&eacute;rieux: Key Developments

Table 50 Thermo Fisher Scientific, Inc.: Overview

Table 51 Thermo Fisher Scientific, Inc.: Product Portfolio

Table 52 Thermo Fisher Scientific, Inc.: Key Developments

Table 53 Ortho Clinical Diagnostics, Inc.: Overview

Table 54 Ortho Clinical Diagnostics, Inc.: Product Portfolio

Table 55 Ortho Clinical Diagnostics, Inc.: Key Developments

Table 56 Becton, Dickinson and Company: Overview

Table 57 Becton, Dickinson and Company: Product Portfolio

Table 58 Becton, Dickinson and Company: Key Developments

Table 59 Beckman Coulter (Danaher Corporation): Overview

Table 60 Beckman Coulter (Danaher Corporation): Product Portfolio

Table 61 Beckman Coulter (Danaher Corporation): Key Developments

List of Figures

Figure 1 Global Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 2 Global Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 3 Global Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 4 Global Blood Screening Market Share, By Region, 2021 &amp; 2030 (%)

Figure 5 Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 6 Global Blood Screening Market Y-o-Y Growth, By Technology, 2021-2030 (%)

Figure 7 Next-Generation Sequencing (NGS): Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 8 Nucleic Acid Test (NAT): Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 9 Enzyme-Linked Immunosorbent Assay (ELISA): Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 10 Western Blot Assay: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 11 Rapid Tests: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 12 Others: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 13 Global Blood Screening Market Y-o-Y Growth, By Product Type, 2021-2030 (%)

Figure 14 Instruments: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 15 Reagents &amp; Kits: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 16 Software and Services: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 17 Global Blood Screening Market Y-o-Y Growth, By End-User, 2021-2030 (%)

Figure 18 Hospitals: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 19 Blood Banks: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 20 Others: Global Blood Screening Market Value, 2021-2030 ($ Million)

Figure 21 Global Blood Screening Market Y-o-Y Growth, By Region, 2021-2030 (%)

Figure 22 North America Blood Screening Market Value, 2021-2030 ($ Million)

Figure 23 North America Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 24 North America Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 25 North America Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 26 North America Blood Screening Market Share, By Country, 2021 &amp; 2030 (%)

Figure 27 South America Blood Screening Market Value, 2021-2030 ($ Million)

Figure 28 South America Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 29 South America Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 30 South America Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 31 South America Blood Screening Market Share, By Country, 2021 &amp; 2030 (%)

Figure 32 Europe Blood Screening Market Value, 2021-2030 ($ Million)

Figure 33 Europe Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 34 Europe Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 35 Europe Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 36 Europe Blood Screening Market Share, By Country, 2021 &amp; 2030 (%)

Figure 37 Asia-Pacific Blood Screening Market Value, 2021-2030 ($ Million)

Figure 38 Asia-Pacific Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 39 Asia-Pacific Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 40 Asia-Pacific Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 41 Asia-Pacific Blood Screening Market Share, By Country, 2021 &amp; 2030 (%)

Figure 42 Middle East &amp; Africa Blood Screening Market Value, 2021-2030 ($ Million)

Figure 43 the Middle East &amp; Africa Blood Screening Market Share, By Technology, 2021 &amp; 2030 (%)

Figure 44 Middle East &amp; Africa Blood Screening Market Share, By Product Type, 2021 &amp; 2030 (%)

Figure 45 Middle East &amp; Africa Blood Screening Market Share, By End-User, 2021 &amp; 2030 (%)

Figure 46 Bio-Rad Laboratories, Inc.: Financials

Figure 47 Grifols: Financials

Figure 48 Abbott Laboratories: Financial

Figure 49 F. Hoffmann-La Roche: Financials

Figure 50 Siemens Healthineers: Financials

Figure 51 Biom&eacute;rieux : Financials

Figure 52 Thermo Fisher Scientific, Inc.: Financials

Figure 53 Ortho Clinical Diagnostics, Inc.: Financials

Figure 54 Becton, Dickinson and Company: Financials

Figure 55 Beckman Coulter (Danaher Corporation): Financials

<h3>&nbsp;</h3>

&nbsp;

Blood Screening Market Size, Share, Industry, Forecast and outlook (2023-2030)

Newborn Screening Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 November 29

Starting from

Blood Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 March 24

Starting from

Blood Collection Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 07

Starting from

Blood And Blood Products Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 28

Starting from